Clicks GroupCLCGY +1.96%83 3-Year RORE % is 31.95 as of Feb. 2026. GuruFocus rates CLCGY with a GF Score™ of 83/100 and a GF Value™ of $49.62 (Significantly Undervalued). Among 605 Healthcare Providers & Services companies, Clicks Group ranks better than 71.74% on this metric.
Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
Clicks Group's 3-Year RORE % for the quarter that ended in Feb. 2026 was 31.95%.
The industry rank for Clicks Group's 3-Year RORE % or its related term are showing as below:
CLCGY's 3-Year RORE % is ranked better than 71.74% of 605
companies
in the Healthcare Providers & Services industry
Industry Median: -0.32
vs CLCGY: 31.95
Clicks Group (OTCPK:CLCGY) 3-Year RORE % Explanation
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
Clicks Group 3-Year RORE % Related Terms
Clicks Group 3-Year RORE % Historical Data
* Premium members only.
The historical data trend for Clicks Group's 3-Year RORE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Clicks Group's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Clicks Group 3-Year RORE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Clicks Group's 3-Year RORE % distribution charts can be found below:
* The bar in red indicates where Clicks Group's 3-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Feb. 2026 and 3-year before.
Clicks Group (CLCGY) has a 3-Year RORE % of 31.95 as of Feb. 2026. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Clicks Group and its competitors. According to the industry distribution chart, Clicks Group ranks #171 out of 605 companies in the Healthcare Providers & Services industry, placing it in the top 28.3%.
Is Clicks Group's 3-Year RORE % too high?
Clicks Group's current 3-Year RORE % is 31.95. Based on the distribution chart, Clicks Group ranks #171 out of 605 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Clicks Group has a GF Score™ of 83/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Clicks Group's 3-Year RORE % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Clicks Group ranks #171 out of 605 companies for 3-Year RORE %. This puts Clicks Group in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Healthcare Providers & Services company?
A good 3-Year RORE % depends on the Healthcare Providers & Services industry context. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Clicks Group and its competitors. Clicks Group's current 3-Year RORE % is 31.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clicks Group stock overvalued right now?
Based on GuruFocus' analysis, Clicks Group (CLCGY) is currently considered Significantly Undervalued. The stock's GF Value™ is $49.62, compared to a current price of $29.15 — trading 41.3% below its estimated fair value. The current 3-Year RORE % is 31.95. Clicks Group's overall GF Score™ is 83/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Clicks Group (CLCGY), the current 3-Year RORE % is 31.95 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Clicks Group (CLCGY) Overvalued in 2026?
Based on GuruFocus' analysis, Clicks Group stock appears to be undervalued.
The current stock price of $29.15 is trading 41.3% below its estimated GF Value™ of $49.62.
GuruFocus considers Clicks Group to be Significantly Undervalued.
Key valuation signals for CLCGY:
3-Year RORE %: 31.95
GF Value™: $49.62 vs. price of $29.15 (41.3% below fair value)
No single metric tells the full story. See the CLCGY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Clicks Group Ltd operates prominently in health, beauty, and wellness retail across southern Africa. The company predominantly operates a retail pharmacy chain in South Africa, with a limited number of operations in bordering countries. The company has a portfolio of retail franchise brands including The Body Shop, M-Kem, and Sorbet among others. The company's business segments include Retail and Distribution. The company generates revenue from in-store and online sales of health, beauty, and wellness items, plus wholesale pharmaceutical distribution. Geographically, the maximum revenue is generated from South Africa.
83GF Score
Get the complete analysis for CLCGY
3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CLCGY has been successfully added to your 
